Introduction: Heart failure, the final stage of most heart diseases, is responsible for high mortality. The aim of this work was to study the evolutionary profile of heart failure with reduced ejection fraction (HFrEF) among patients followed at the University Cardiology Clinic of Cotonou. Material and Method: This was a descriptive, observational, longitudinal and analytical study conducted from January 2021 to June 2022. It included by exhaustive sampling patients who presented with HFrEF. Inclusion was made during post-hospitalization follow-up. The variables studied were clinical presentation, CHARLSON score summarizing the burden of comorbidities, mortality rate and number of re-hospitalizations. Results: A total of one hundred and thirteen (113) patients were included in the study. Mean age was 53.2 ± 17.3 years, with a sex ratio of 1.75. Dyspnea was stage III in 59.5% of patients and stage IV in 8.1%. The CHARLSON score was greater than or equal to 3 in 12.4% of cases. The re-hospitalization rate was 18.6%, and the one-year mortality rate was 33.6%. Factors associated with death included advanced age, left ventricular ejection fraction below 30% and a CHARLSON score greater than or equal to 3. Conclusion: HFrEF is a severe pathology associated with a poor prognosis. These findings underscore the critical need for early and aggressive management strategies, with the rigorous control of associated comorbidities.
| Published in | Cardiology and Cardiovascular Research (Volume 9, Issue 4) |
| DOI | 10.11648/j.ccr.20250904.17 |
| Page(s) | 159-166 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2025. Published by Science Publishing Group |
Heart Failure, Mortality, Re-hospitalization
| [1] | Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014 Apr 1; 63(12): 1123-1133. https://doi.org/10.1016/j.jacc.2013.11.053 Epub 2014 Feb 5. |
| [2] |
Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nature Reviews Cardiology. 2011; 8(1): 30-41.
https://doi.org/10.1038/nrcardio.2010.165. Epub 2010 Nov 9. |
| [3] | Bloom MW, Greenberg B, Jaarsma T, Januzzi JL, Lam CSP, Maggioni AP et al. Heart failure with reduced ejection fraction. Nat Rev Dis Primers. 2017; 24(3): 17058. |
| [4] | Kyre A. Évaluation de la prise en charge thérapeutique de l’insuffisance cardiaque chronique à fraction d’éjection réduite par les médecins généralistes en Gironde [Evaluation of the therapeutic management of chronic heart failure with reduced ejection fraction by general practitioners in Gironde]. Médecine Humaine et Pathologie. 2018. Dumas-01970160. |
| [5] | Assogba G. Suivi et évolution de l'insuffisance cardiaque au CNHU-HKM de Cotonou [Follow-up and evolution of heart failure at CNHU-HKM of cotonou] [Specialist Diploma Thesis]. Cotonou: Université d' Abomey calavi; 2013. |
| [6] | Mignard P. (page consulted December 18, 2017). Medicalcul Micromega Software System 2018, [Online]. Available from: |
| [7] | Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2023 ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2023; 44(36): 3948–4036. |
| [8] | Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407-77. |
| [9] | Setter NW, Peres ML, De Almeida BMM, Petterle RR, Raboni SM. Charlson comorbidity index scores and in-hospital prognosis of patients with severe acute respiratory infections. Internal Medicine Journal. 2020; 50(6): 691-7. |
| [10] | Gahou A. Évaluation à moyen terme d'un programme simplifié d'éducation thérapeutique et d'autosurveillance pour les patients souffrant d'insuffisance cardiaque suivis à la Clinique Universitaire de Cardiologie du Centre National Hospitalier et Universitaire Hubert Koutoukou Maga de Cotonou [Medium-term evaluation of a simplified therapeutic education and self-monitoring program for heart failure patients followed at the University Cardiology Clinic of the National Teaching Hospital Hubert Koutoukou Maga of Cotonou] [Specialist Diploma Thesis]. Cotonou: Université d'Abomey Calavi; 2022. |
| [11] | Hountondji Denadi J. Fréquence et évolution de l'insuffisance cardiaque à Cotonou [Frequency and evolution of heart failure in Cotonou] [Thesis]: Université d'Abomey Calavi; 2000. |
| [12] | Lawani Bolarin P. Prise en charge de l'insuffisance cardiaque à FEVG préservée: Expérience du CNHU-HKM de Cotonou [Management of heart failure with preserved ejection fraction: Experience of the CNHU-HKM of Cotonou] [Specialist Diploma Thesis]. Cotonou: Université d'Abomey Calavi; 2016. |
| [13] | Arnaud Sonou, Léopold Codjo, Murielle Hounkponou, Philippe Mahouna Adjagba, Prudence Wachinou, Rosaire Bognon et al. Déterminants de l’insuffisance cardiaque aiguë au cours de l’infarctus du myocarde [Determinants of acute heart failure during myocardial infarction]. Pan African Medical Journal. 2018; 29: 130. |
| [14] | Pio M, Afassinou Y, Pessinaba S, Baragou S, N'djao J, Atta B, Ehlan E, Damorou F, Goeh-Akué E. Epidémiologie et étiologies des insuffisances cardiaques à Lomé [Epidemiology and etiology of heart failure in Lome]. Pan Afr Med J. 2014 Jun 25; 18: 183. |
| [15] | Léopold, C. H., Mahougnon, D. S. H., Alphonse, B. C. O., Mawuton, S. T. G., Melic, B. C., Nicolas, A. H. and Dèdonougbo, H. M. (2022) Outcomes of Patients with Heart Failure followed in a Cardiological Setting to Parakou from 2016 to 2020. World Journal of Cardiovascular Diseases, 12, 490-506. |
| [16] | Kodingar D. Mise en place d'une unité thérapeutique d'insuffisance cardiaque en hôpital de jour à l'USERC [Implementation of a Day Hospital heart failure therapeutic unit at USERC] [Specialist Diploma Thesis]. Cotonou: Université d'Abomey Calavi; 2016. |
| [17] | Ouédraogo EWM, Ouédraogo S, Bamouni J, Banda A, Kientega H, Ouédraogo T, et al. Altered ejection fraction heart failure in rural Africa: clinical and paraclinical characteristics in Ouahigouya (Burkina Faso). Health Sciences and Diseases. 2022; 23 (1): 46-50. |
| [18] | Kenou A. Aspect clinique, paraclinique et thérapeutique de l’insuffisance cardique de l’adulte à Porto-Novo [Clinical, paraclinical and therapeutic aspects of adult heart failure in Porto-Novo] [Thesis]. Faculté des Sciences de la Santé, Université d'Abomey-Calavi (Benin) 2016. N°1933. 51p. |
| [19] |
Sani MU, Davison BA, Cotter G, Sliwa K, Edwards C, Liu L et al. Renal dysfunction in African patients with acute heart failure. Eur J Heart Fail. 2014 Jul; 16(7): 718-28.
https://doi.org/10.1002/ejhf.103 Epub 2014 Jun 24. |
| [20] | Ambroise GL, Justin DB, Florent K, Micesse T, Stéphane KK, Jean-Baptiste AK. Heart failure (HF) at the Abidjan Heart Institute: clinico-electrocardiographic and echocardiographic aspects. Rev int sc méd Abj. 2019; 21(3): 206-211. |
| [21] | Sossou I. Aspects évolutifs et pronostiques de l'insuffisance cardiaque en cardiologie à Parakou [Evolutionary and prognostic aspects of heart failure in cardiology in Parakou] [Thesis]. Parakou: Université de Parakou; 2016. N°426. 166p. |
| [22] | Curtis JP, Sokol SI, Wang Y, Rathore SS, Ko DT, Jadbabaie F et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol. 2003 Aug 20; 42(4): 736-42. https://doi.org/10.1016/s0735-1097(03)00789-7 |
| [23] |
Angaran P, Dorian P, Ha ACT, Thavendiranathan P, Tsang W, Leong-Poi H et al. Association of Left Ventricular Ejection Fraction with Mortality and Hospitalizations. J Am Soc Echocardiogr. 2020 Jul; 33(7): 802-811.e6.
https://doi.org/10.1016/j.echo.2019.12.016 . Epub 2020 Mar 9. |
APA Style
Sonou, D. J. A., Tchaniga, B., Tiomon, B., Agboton, B., Adeossi, A., et al. (2025). Evolution of Heart Failure with Reduced Ejection Fraction in a Cardiology Clinic in Cotonou. Cardiology and Cardiovascular Research, 9(4), 159-166. https://doi.org/10.11648/j.ccr.20250904.17
ACS Style
Sonou, D. J. A.; Tchaniga, B.; Tiomon, B.; Agboton, B.; Adeossi, A., et al. Evolution of Heart Failure with Reduced Ejection Fraction in a Cardiology Clinic in Cotonou. Cardiol. Cardiovasc. Res. 2025, 9(4), 159-166. doi: 10.11648/j.ccr.20250904.17
AMA Style
Sonou DJA, Tchaniga B, Tiomon B, Agboton B, Adeossi A, et al. Evolution of Heart Failure with Reduced Ejection Fraction in a Cardiology Clinic in Cotonou. Cardiol Cardiovasc Res. 2025;9(4):159-166. doi: 10.11648/j.ccr.20250904.17
@article{10.11648/j.ccr.20250904.17,
author = {Djidjoho Joël Arnaud Sonou and Baudouin Tchaniga and Baudouin Tiomon and Bruno Agboton and Armel Adeossi and Rineste Sagbohan and Witesse Houndjo and Ibrahim Gbadamassi and Marie Noëlle Tamekem and David Mawu-Kolo Bokodaho and Francis Agué Soummonni and David Dossou and Xavier Fadonougbo and Philippe Agbalika and Elodie Tondji and Murielle Hounkponou and Léopold Houétondji Codjo},
title = {Evolution of Heart Failure with Reduced Ejection Fraction in a Cardiology Clinic in Cotonou},
journal = {Cardiology and Cardiovascular Research},
volume = {9},
number = {4},
pages = {159-166},
doi = {10.11648/j.ccr.20250904.17},
url = {https://doi.org/10.11648/j.ccr.20250904.17},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20250904.17},
abstract = {Introduction: Heart failure, the final stage of most heart diseases, is responsible for high mortality. The aim of this work was to study the evolutionary profile of heart failure with reduced ejection fraction (HFrEF) among patients followed at the University Cardiology Clinic of Cotonou. Material and Method: This was a descriptive, observational, longitudinal and analytical study conducted from January 2021 to June 2022. It included by exhaustive sampling patients who presented with HFrEF. Inclusion was made during post-hospitalization follow-up. The variables studied were clinical presentation, CHARLSON score summarizing the burden of comorbidities, mortality rate and number of re-hospitalizations. Results: A total of one hundred and thirteen (113) patients were included in the study. Mean age was 53.2 ± 17.3 years, with a sex ratio of 1.75. Dyspnea was stage III in 59.5% of patients and stage IV in 8.1%. The CHARLSON score was greater than or equal to 3 in 12.4% of cases. The re-hospitalization rate was 18.6%, and the one-year mortality rate was 33.6%. Factors associated with death included advanced age, left ventricular ejection fraction below 30% and a CHARLSON score greater than or equal to 3. Conclusion: HFrEF is a severe pathology associated with a poor prognosis. These findings underscore the critical need for early and aggressive management strategies, with the rigorous control of associated comorbidities.},
year = {2025}
}
TY - JOUR T1 - Evolution of Heart Failure with Reduced Ejection Fraction in a Cardiology Clinic in Cotonou AU - Djidjoho Joël Arnaud Sonou AU - Baudouin Tchaniga AU - Baudouin Tiomon AU - Bruno Agboton AU - Armel Adeossi AU - Rineste Sagbohan AU - Witesse Houndjo AU - Ibrahim Gbadamassi AU - Marie Noëlle Tamekem AU - David Mawu-Kolo Bokodaho AU - Francis Agué Soummonni AU - David Dossou AU - Xavier Fadonougbo AU - Philippe Agbalika AU - Elodie Tondji AU - Murielle Hounkponou AU - Léopold Houétondji Codjo Y1 - 2025/12/09 PY - 2025 N1 - https://doi.org/10.11648/j.ccr.20250904.17 DO - 10.11648/j.ccr.20250904.17 T2 - Cardiology and Cardiovascular Research JF - Cardiology and Cardiovascular Research JO - Cardiology and Cardiovascular Research SP - 159 EP - 166 PB - Science Publishing Group SN - 2578-8914 UR - https://doi.org/10.11648/j.ccr.20250904.17 AB - Introduction: Heart failure, the final stage of most heart diseases, is responsible for high mortality. The aim of this work was to study the evolutionary profile of heart failure with reduced ejection fraction (HFrEF) among patients followed at the University Cardiology Clinic of Cotonou. Material and Method: This was a descriptive, observational, longitudinal and analytical study conducted from January 2021 to June 2022. It included by exhaustive sampling patients who presented with HFrEF. Inclusion was made during post-hospitalization follow-up. The variables studied were clinical presentation, CHARLSON score summarizing the burden of comorbidities, mortality rate and number of re-hospitalizations. Results: A total of one hundred and thirteen (113) patients were included in the study. Mean age was 53.2 ± 17.3 years, with a sex ratio of 1.75. Dyspnea was stage III in 59.5% of patients and stage IV in 8.1%. The CHARLSON score was greater than or equal to 3 in 12.4% of cases. The re-hospitalization rate was 18.6%, and the one-year mortality rate was 33.6%. Factors associated with death included advanced age, left ventricular ejection fraction below 30% and a CHARLSON score greater than or equal to 3. Conclusion: HFrEF is a severe pathology associated with a poor prognosis. These findings underscore the critical need for early and aggressive management strategies, with the rigorous control of associated comorbidities. VL - 9 IS - 4 ER -